Cargando…
Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders
Mutations in nuclear genes encoding for mitochondrial proteins very long-chain acyl-CoA dehydrogenase (VLCAD) and trifunctional protein (TFP) cause rare autosomal recessive disorders. Studies in fibroblasts derived from patients with mutations in VLCAD and TFP exhibit mitochondrial defects. To gain...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970426/ https://www.ncbi.nlm.nih.gov/pubmed/33725513 http://dx.doi.org/10.1016/j.redox.2021.101923 |
_version_ | 1783666425814056960 |
---|---|
author | Raimo, Serena Zura-Miller, Gabriella Fezelinia, Hossein Spruce, Lynn A. Zakopoulos, Iordanis Mohsen, Al-Walid Vockley, Jerry Ischiropoulos, Harry |
author_facet | Raimo, Serena Zura-Miller, Gabriella Fezelinia, Hossein Spruce, Lynn A. Zakopoulos, Iordanis Mohsen, Al-Walid Vockley, Jerry Ischiropoulos, Harry |
author_sort | Raimo, Serena |
collection | PubMed |
description | Mutations in nuclear genes encoding for mitochondrial proteins very long-chain acyl-CoA dehydrogenase (VLCAD) and trifunctional protein (TFP) cause rare autosomal recessive disorders. Studies in fibroblasts derived from patients with mutations in VLCAD and TFP exhibit mitochondrial defects. To gain insights on pathological changes that account for the mitochondrial deficits we performed quantitative proteomic, biochemical, and morphometric analyses in fibroblasts derived from subjects with three different VLCAD and three different TFP mutations. Proteomic data that was corroborated by antibody-based detection, indicated reduced levels of VLCAD and TFP protein in cells with VLCAD and TFP mutations respectively, which in part accounted for the diminished fatty acid oxidation capacity. Decreased mitochondrial respiratory capacity in cells with VLCAD and TFP mutations was quantified after glucose removal and cells with TFP mutations had lower levels of glycogen. Despite these energetic deficiencies, the cells with VLCAD and TFP mutations did not exhibit changes in mitochondria morphology, distribution, fusion and fission, quantified by either confocal or transmission electron microscopy and corroborated by proteomic and antibody-based protein analysis. Fibroblasts with VLCAD and to a lesser extend cells with TFP mutations had increased levels of mitochondrial respiratory chain proteins and proteins that facilitate the assembly of respiratory complexes. With the exception of reduced levels of catalase and glutathione S-transferase theta-1 in cells with TFP mutations, the levels of 45 proteins across all major intracellular antioxidant networks were similar between cells with VLCAD and TFP mutations and non-disease controls. Collectively the data indicate that despite the metabolic deficits, cells with VLCAD and TFP mutations maintain their proteomic integrity to preserve cellular and mitochondria architecture, support energy production and protect against oxidative stress. |
format | Online Article Text |
id | pubmed-7970426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-79704262021-03-19 Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders Raimo, Serena Zura-Miller, Gabriella Fezelinia, Hossein Spruce, Lynn A. Zakopoulos, Iordanis Mohsen, Al-Walid Vockley, Jerry Ischiropoulos, Harry Redox Biol Research Paper Mutations in nuclear genes encoding for mitochondrial proteins very long-chain acyl-CoA dehydrogenase (VLCAD) and trifunctional protein (TFP) cause rare autosomal recessive disorders. Studies in fibroblasts derived from patients with mutations in VLCAD and TFP exhibit mitochondrial defects. To gain insights on pathological changes that account for the mitochondrial deficits we performed quantitative proteomic, biochemical, and morphometric analyses in fibroblasts derived from subjects with three different VLCAD and three different TFP mutations. Proteomic data that was corroborated by antibody-based detection, indicated reduced levels of VLCAD and TFP protein in cells with VLCAD and TFP mutations respectively, which in part accounted for the diminished fatty acid oxidation capacity. Decreased mitochondrial respiratory capacity in cells with VLCAD and TFP mutations was quantified after glucose removal and cells with TFP mutations had lower levels of glycogen. Despite these energetic deficiencies, the cells with VLCAD and TFP mutations did not exhibit changes in mitochondria morphology, distribution, fusion and fission, quantified by either confocal or transmission electron microscopy and corroborated by proteomic and antibody-based protein analysis. Fibroblasts with VLCAD and to a lesser extend cells with TFP mutations had increased levels of mitochondrial respiratory chain proteins and proteins that facilitate the assembly of respiratory complexes. With the exception of reduced levels of catalase and glutathione S-transferase theta-1 in cells with TFP mutations, the levels of 45 proteins across all major intracellular antioxidant networks were similar between cells with VLCAD and TFP mutations and non-disease controls. Collectively the data indicate that despite the metabolic deficits, cells with VLCAD and TFP mutations maintain their proteomic integrity to preserve cellular and mitochondria architecture, support energy production and protect against oxidative stress. Elsevier 2021-03-02 /pmc/articles/PMC7970426/ /pubmed/33725513 http://dx.doi.org/10.1016/j.redox.2021.101923 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Paper Raimo, Serena Zura-Miller, Gabriella Fezelinia, Hossein Spruce, Lynn A. Zakopoulos, Iordanis Mohsen, Al-Walid Vockley, Jerry Ischiropoulos, Harry Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title | Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title_full | Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title_fullStr | Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title_full_unstemmed | Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title_short | Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
title_sort | mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970426/ https://www.ncbi.nlm.nih.gov/pubmed/33725513 http://dx.doi.org/10.1016/j.redox.2021.101923 |
work_keys_str_mv | AT raimoserena mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT zuramillergabriella mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT fezeliniahossein mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT sprucelynna mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT zakopoulosiordanis mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT mohsenalwalid mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT vockleyjerry mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders AT ischiropoulosharry mitochondrialmorphologybioenergeticsandproteomicresponsesinfattyacidoxidationdisorders |